NCT06144814 - A Comparison of Hyaluronic Acid and Estradiol Treatment in Vulvovaginal Atrophy. | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

April 5, 2023

Primary Completion Date

September 15, 2023

Study Completion Date

September 30, 2023

Conditions

Vulvovaginal Atrophy

Interventions

DRUG

Hyaluronic acid vaginal gel

. Group II received 5 mg of vaginal hyaluronic acid every day for 14 days, then 2 days a week for the next 2 weeks. Hyaluronic acid gel for vaginal use was supplied by ORTHOGEN®. The treatment period lasted 1 month in both groups.

DRUG

Estrogen vaginal use form

Group I received 25 µg vaginal estrodiol (Vagifem®). 1 tablet a day for two weeks, then 2 times a week for the next 2 weeks.

Trial Locations (1)

06530

Turkey, Ankara